And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda includes catching up on our reading, promenading a few miles with the official mascot, and taking a few naps. And what about you? This may be a good time to touch base with those feeling isolated, or you can support the local economy by placing an order with a nearby restaurant. You may also want to check on when you can get vaccinated. Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you soon. …

Pfizer (PFE) and BioNTech (BNTX) agreed to supply their Covid-19 vaccine to the COVAX vaccine access scheme co-led by the World Health Organization, the latest in a series of shots to be included in the project aimed at lower-income countries, Reuters reports. Details on the size of the deal or the price per dose COVAX would pay were not immediately clear, but the allotment would likely be relatively small, because the doses are primarily meant for health care workers in the countries that COVAX serves.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What’s included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Source: STATNEWS.COM

Leave a Reply

ArabicChinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

[mc4wp_form id="449"]